unknown
Stage
2
Investors
About
Aelis Farma develops novel pharmacological inhibitors targeting the CB1 receptor signaling pathway to treat brain disorders such as cognitive deficits and cannabis use disorders.
Explore Aelis Farma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.